<DOC>
	<DOCNO>NCT02265952</DOCNO>
	<brief_summary>This open-label , single-arm study assess reduction low-density lipoprotein cholesterol ( LDL-C ) REGN1500 patient homozygous familial hypercholesterolemia ( HoFH ) .</brief_summary>
	<brief_title>Study REGN1500 Patients With Homozygous Familial Hypercholesterolemia ( HoFH )</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Hyperlipoproteinemia Type II</mesh_term>
	<criteria>1 . Men woman â‰¥18 year age time screen visit 2 . Diagnosis homozygous familial hypercholesterolemia ( HoFH ) 3 . Willing consistently maintain usual diet duration study 1 . Background medical lipid modify therapy stable least 4 week ( 6 week fibrates ) prior screen visit 2 . Having undergone lipid apheresis within 4 week prior screen visit 3 . Use another investigational drug therapy within 30 day least 5 halflives ( whichever longer ) prior screen visit 4 . Previous participation clinical trial REGN1500 Note : The information list intend contain consideration relevant patient 's potential participation clinical trial therefore inclusion/ exclusion criterion list .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>